Immunovia has completed a directed share issue of approximately SEK 324 million.
Immunovia intends to use the net proceeds from the share issue to accelerate previously announced launching preparations, build a US sales and key account organization, marketing campaigns and other sales efforts, and further investments in the company's product development platform.
The share issue generated strong demand from reputable institutions in Sweden and internationally, such as Swedbank Robur, Handelsbanken Fonder, Alfred Berg Kapitalförvaltning AB, Nyenburgh Investment Partners and Bonit Capital.
Vator Securites AB acted as Sole Bookrunner in the transaction and Erik Penser Bank AB acted as issuer agent. Baker McKenzie acted as legal adviser to Immunovia. Baker McKenzie's team consisted mainly of Joakim Falkner and Ian Gulam.